Presentation TCT 2013 Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies Presenter: Paul Grayburn October 30, 2013 REGISTER for free or LOG IN to view this content Left Atrial Appendage Presentation TCT 2013 Up Next Presentation TCT 2013 Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Following Ex Vivo... Presenter: Steven Burke January 31, 2013 More slides + Presentation Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent? Presenter: Marco Valgimigli January 16, 2013 Presentation TCT 2013 Prevalence, Correlation and Clinical Outcome of Intra-procedural Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Coronary Syndrome Presenter: Yingjia Xu January 31, 2013 We Recommend
Presentation TCT 2013 Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Following Ex Vivo... Presenter: Steven Burke January 31, 2013
Presentation Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent? Presenter: Marco Valgimigli January 16, 2013
Presentation TCT 2013 Prevalence, Correlation and Clinical Outcome of Intra-procedural Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Coronary Syndrome Presenter: Yingjia Xu January 31, 2013